(Press-News.org) Oncotarget published "Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®" which reported that the authors developed and analytically validated a comprehensive genomic profiling assay, GEM ExTra, for patients with advanced solid tumors that uses Next Generation Sequencing to characterize whole exomes employing a paired tumor-normal subtraction methodology.
The assay detects single nucleotide variants, indels, focal copy number alterations, TERT promoter region, as well as tumor mutation burden and microsatellite instability status.
Additionally, the assay incorporates whole transcriptome sequencing of the tumor sample that allows for the detection of gene fusions and select special transcripts, including AR-V7, EGFR vIII, EGFRvIV, and MET exon 14 skipping events.
The assay has a mean target coverage of 180X for the normal and 400X for tumor DNA including enhanced probe design to facilitate the sequencing of difficult regions.
Proprietary bioinformatics, paired with comprehensive clinical curation results in reporting that defines clinically actionable, FDA-approved, and clinical trial drug options for the management of the patient's cancer.
Proprietary bioinformatics, paired with comprehensive clinical curation results in reporting that defines clinically actionable, FDA-approved, and clinical trial drug options for the management of the patient's cancer.
Dr. Thomas Royce from Ashion Analytics, LLC said, "Cancer has a high clinical burden and oncology therapies are expensive."
There are a few predominant laboratories that perform CGP tumor tests with the intended use of providing clinical decision support for therapy selection for cancer.
GEM ExTra uses Whole Exome Sequencing for tumor DNA profiling, testing for all protein-coding genes in a sample, indicating that the test will be comprehensive now and in the future.
GEM ExTra provides somatic variant calling based on tumor and matched germline sequencing allowing for improved discrimination of somatic variants from rare, benign germline variants when compared to tumor-only analysis used by other CGP tests.
GEM ExTra also identifies clinically actionable transcript variants and fusion genes through transcriptome sequencing. These are typically undetectable through conventional CGP tests, which only employ DNA analysis.
The test is designed to provide healthcare professionals with clinically actionable information to guide patient management decisions based on the genomic profile of a cancer patient's tumor.
The Royce Research Team concluded in their Oncotarget Research Output that the analytic performance characteristics of the assay were validated by comparison of patient samples to reference assays, and actionable variants were identified in tumors to guide oncology patient management decisions.
The test was utilized in over 1400 patient samples during a period of April 2018 and December 2019 across cancer centers to detect multiple actionable alterations in a variety of cancer types.
Reports of these actionable mutations were utilized to inform patient care, including matching patients to available targeted therapies or clinical trials.
The data from the clinical laboratory testing is generally concordant with data in the literature and emphasizes the value of the use of this pan-cancer comprehensive genomic test for the clinical management of patients with advanced cancer.
As of December 2019, Ashion was added to the list of commercial laboratories that are designated to identify and refer eligible patients to the NCI-MATCH trial.
Sign up for free Altmetric alerts about this article
DOI - https://doi.org/10.18632/oncotarget.27945
Full text - https://www.oncotarget.com/article/27945/text/
Correspondence to - Thomas Royce - TRoyce@ashion.com
Keywords -
comprehensive genomic profiling,
whole exome sequencing,
RNA sequencing,
precision medicine,
pan-cancer
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
Scientists have made a major breakthrough in the study of embryonic development and how it can be impacted by external factors such as climate change.
Researchers at the University of Plymouth have developed a cutting edge technique which enables them to instantly examine the biological traits and behaviours of developing embryos as an energy signature, rather than focusing on individual characteristics.
The method, outlined in a study published in BMC Bioinformatics, is built around timelapse video captured by the researchers of aquatic animals - specifically, the embryos of a freshwater pond snail Radix ...
Using the Five-hundred-meter Aperture Spherical radio Telescope (FAST), a research team led by Prof. HAN Jinlin from National Astronomical Observatories of Chinese Academy of Sciences (NAOC) has discovered 201 pulsars, including many very faint pulsars, 40 millisecond pulsars (MSPs), and 16 pulsars in binaries.
These discoveries were published in Research in Astronomy and Astrophysics.
Pulsars are compact remnants of the death of bright, massive stars. They have the strongest magnetic field, highest density and fastest rotation of any celestial body in the Universe, and show significant ...
Nearly two thirds (61%) expressed concern about their worsening mood in Lockdown and associated restrictions1.
34% said they felt more anxious and 28% felt more depressed during Lockdown and associated restrictions1.
Coffee helped lift nearly half (44%) of adult's negative moods in Lockdown and associated restrictions1.
A new pan-European survey funded by the Institute for Scientific Information on Coffee exploring the impact of COVID-19 Lockdowns and associated restrictions (in those countries where there has been no Lockdown), has found that nearly two thirds of adults (61%) expressed concern about their worsening mood; two times higher than those concerned about physical inactivity (24%)1.
Understanding the effects of COVID-19 restrictions ...
Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.
More than a year into the COVID-19 pandemic, the RT-PCR test remains the gold standard for detection of the SARS-CoV-2 virus. This method requires trained personnel at every step, from collection of nasopharyngeal swab (NPS) samples to interpretation of the results; in addition, the entire process ranges from 24-48 hours on average. As the virus can be transmitted by an infected person before symptoms ...
Fixed-dose combination of nivolumab and relatlimab holds the cancer in check significantly longer than nivolumab alone
This is the first regimen to demonstrate a statistical benefit over anti-PD-1 monotherapy in metastatic melanoma
BOSTON - A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a phase 3 clinical trial involving 714 patients. Dana-Farber Cancer Institute investigators co-led the study. Findings will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, being held ...
HOUSTON -- The glutaminase (GLS1) inhibitor IACS-6274, discovered and developed by The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division, appears to be well-tolerated with successful target inhibition and early signs of anti-tumor activity in a biomarker-driven Phase I trial. Interim results of the study will be presented at the 2021 American Society for Clinical Oncology (ASCO) Annual Meeting on June 4.
On the trial, 17 of 20 evaluable patients achieved a best response of stable disease, with a disease control rate of 60% at 12 weeks. Six patients with biomarker-defined advanced cancers ...
URBANA, Ill. - Women's ability to work as entrepreneurs can help alleviate poverty and malnutrition in developing countries. As local governments and development organizations aim to encourage business opportunities, it's important to identify projects suited for women's lives in rural households.
The soy kit, which includes common household items such as a pot, spoon, thermometer, and cheese cloth, enables entrepreneurs to create value-added products from soy in small-scale household settings. The kit has potential to improve the economic conditions of Malawi women in a sustainable way, a University of Illinois study concludes.
"The larger issue is about adding value to agricultural products in the developing world as a means ...
Boulder, Colo., USA: The Paleozoic era culminated 251.9 million years ago in the most severe mass extinction recorded in the geologic record. Known as the "great dying," this event saw the loss of up to 96% of all marine species and around 70% of terrestrial species, including plants and insects.
The consensus view of scientists is that volcanic activity at the end of the Permian period, associated with the Siberian Traps Large Igneous Province, emitted massive quantities of greenhouse gases into the atmosphere over a short time interval. This caused a spike in global temperatures and a cascade of other deleterious ...
Keto, gluten-free, organic: If a pet owner is on a specific diet, chances are their dog is on it, too, a new U of G study reveals.
But when it comes to a grain-free diet, owners seem to choose it more for their dogs than themselves, the study also found.
"It demonstrates that many variables, not just dietary habits, influence the selection of dog food," said study lead author Sydney Banton, a master's student in U of G's Department of Animal Biosciences.
The international Pet Food Consumer Habit Survey is the first of its kind to examine factors involved in ...
NEWPORT, Ore. - The population of white sharks that call the Central California coast their primary home is holding steady at about 300 animals and shows some signs of growth, a new long-term study of the species has shown.
Between 2011 and 2018, researchers were able to identify hundreds of individual adult and subadult white sharks, which are not fully mature but are old enough to prey on marine mammals. They used that information to develop estimates of the sharks' abundance.
"The finding, a result of eight years of photographing and identifying individual ...
